There is more evidence of IRE1α suppressing different pro-inflammatory anti-tumor interferon signaling [143] and promoting the production of prostaglandin E2 (PGE2) [144], a known promoter of Treg differentiation [145], in prostate cancer and NSCLC, respectively. The gene discussed is ERN1; the disease is prostate carcinoma.